English | 繁體

Search in the results

UM

Browse/Search Results:  1-4 of 4 Help

Selected(0)Clear Items/Page:    Sort:
Substantial protection against MPTP-associated Parkinson's neurotoxicity in vitro and in vivo by anti-cancer agent SU4312 via activation of MEF2D and inhibition of MAO-B Journal article
Guo, Baojian, Hu, Shengquan, Zheng, Chengyou, Wang, Hongyu, Luo, Fangcheng, Li, Haitao, Cui, Wei, Yang, Xifei, Cui, Guozhen, Mak, Shinghung, Choi, Tony Chung-Lit, Ma, Edmond Dik-Lung, Wang, Yuqiang, Lee, Simon Ming Yuen, Zhang, Zaijun, Han, Yifan. Substantial protection against MPTP-associated Parkinson's neurotoxicity in vitro and in vivo by anti-cancer agent SU4312 via activation of MEF2D and inhibition of MAO-B[J]. NEUROPHARMACOLOGY, 2017, 126, 12-24.
Authors:  Guo, Baojian;  Hu, Shengquan;  Zheng, Chengyou;  Wang, Hongyu;  Luo, Fangcheng; et al.
View | Adobe PDF | Favorite | TC[WOS]:18 TC[Scopus]:20  IF:4.6/4.5 | Submit date：2018/10/31
Parkinson's Disease  Su4312  Neuroprotection  Myocyte Enhancer Factor 2d  Monoamine Oxidase-b  
Substantial protection against MPTP-associated Parkinson's neurotoxicity in vitro and in vivo by anti-cancer agent SU4312 via activation of MEF2D and inhibition of MAO-B Journal article
Guo B., Hu S., Zheng C., Wang H., Luo F., Li H., Cui W., Yang X., Cui G., Mak S., Choi T.C.-L., Ma E.D.-L., Wang Y., Lee S.M.Y., Zhang Z., Han Y.. Substantial protection against MPTP-associated Parkinson's neurotoxicity in vitro and in vivo by anti-cancer agent SU4312 via activation of MEF2D and inhibition of MAO-B[J]. Neuropharmacology, 2017, 126, 12-24.
Authors:  Guo B.;  Hu S.;  Zheng C.;  Wang H.;  Luo F.; et al.
Favorite | TC[WOS]:18 TC[Scopus]:20 | Submit date：2018/11/06
Monoamine Oxidase-b  Myocyte Enhancer Factor 2d  Neuroprotection  Parkinson's Disease  Su4312  
Substantial protection against MPTP-associated Parkinson's neurotoxicity in vitro and in vivo by anti-cancer agent SU4312 via activation of MEF2D and inhibition of MAO-B Journal article
Guo B., Hu S., Zheng C., Wang H., Luo F., Li H., Cui W., Yang X., Cui G., Mak S., Choi T.C.-L., Ma E.D.-L., Wang Y., Lee S.M.Y., Zhang Z., Han Y.. Substantial protection against MPTP-associated Parkinson's neurotoxicity in vitro and in vivo by anti-cancer agent SU4312 via activation of MEF2D and inhibition of MAO-B[J]. Neuropharmacology, 2017, 126, 12-24.
Authors:  Guo B.;  Hu S.;  Zheng C.;  Wang H.;  Luo F.; et al.
Favorite | TC[WOS]:18 TC[Scopus]:20 | Submit date：2018/11/06
Monoamine Oxidase-b  Myocyte Enhancer Factor 2d  Neuroprotection  Parkinson's Disease  Su4312  
No synergism between bis(propyl)-cognitin and rasagiline on protecting dopaminergic neurons in Parkinson's disease mice Journal article
Cheng-you Zheng, Bao-jian Guo, Wei Cai, Wei Cui, Shing-hung Mak, Yu-qiang Wang, Simon Ming-yuen Lee, Yi-fan Han, Zai-jun Zhang. No synergism between bis(propyl)-cognitin and rasagiline on protecting dopaminergic neurons in Parkinson's disease mice[J]. NEURAL REGENERATION RESEARCH, 2016, 11(8), 1339-1346.
Authors:  Cheng-you Zheng;  Bao-jian Guo;  Wei Cai;  Wei Cui;  Shing-hung Mak; et al.
Favorite | TC[WOS]:2 TC[Scopus]:1  IF:5.9/5.2 | Submit date：2020/01/16
Nerve Regeneration  Parkinson's Disease  Bis(Propyl)-cognitin  Rasagiline  Monoamine Oxidase b  Dopamine  Multitarget  Synergism  Neuroprotection  Neural Regeneration